Therapeutic uses of Cannabis sativa L. Current state and future perspectives

Referencias bibliográficas

• Abrams, (2003), Annals of Internal Medicine, 139, pp. 258, 10.7326/0003-4819-139-4-200308190-00008
• Abrams, (2007), Neurology, 68, pp. 515, 10.1212/01.wnl.0000253187.66183.9c
• Afrin, (2020), Cancers, 12, 10.3390/cancers12041033
• Ali, (2015), Pakistan Journal of Pharmaceutical Sciences, 28, pp. 1389
• Allendorfer, (2019), Epilepsy & Behavior, 96, pp. 114, 10.1016/j.yebeh.2019.04.008
• Almog, (2020), European Journal of Pain (United Kingdom), 24, pp. 1505, 10.1002/ejp.1605
• An, (2020), International Journal of Molecular Sciences, 21, pp. 5064, 10.3390/ijms21145064
• Andre, (2016), Frontiers in Plant Science, 7
• Aso, (2013), Journal of Alzheimer’s Disease, 35, pp. 847, 10.3233/JAD-130137
• Aso, (2015), Journal of Alzheimer’s Disease, 43, pp. 977, 10.3233/JAD-141014
• Bari, (2013), FEBS Journal, 280, pp. 3376, 10.1111/febs.12329
• Bar-Lev Schleider, (2018), European Journal of Internal Medicine, 49, pp. 37, 10.1016/j.ejim.2018.01.023
• Basavarajappa, (1998), Brain Research, 793, pp. 212, 10.1016/S0006-8993(98)00175-9
• Basavarajappa, (2017), Journal of Neurochemistry, 142, pp. 624, 10.1111/jnc.14098
• Benito, (2003), The Journal of Neuroscience, 23, pp. 11136, 10.1523/JNEUROSCI.23-35-11136.2003
• Benito, (2007), Journal of Neuroscience, 27, pp. 2396, 10.1523/JNEUROSCI.4814-06.2007
• Bergamaschi, (2011), Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 36, pp. 1219, 10.1038/npp.2011.6
• Bisogno, (2008), Neurochemistry International, 52, pp. 307, 10.1016/j.neuint.2007.06.031
• Biswas, (2017), CNS and Neurological Disorders - Drug Targets, 16, pp. 576, 10.2174/1871527316666170424115008
• Bonini, (2018), Journal of Ethnopharmacology, 227, pp. 300, 10.1016/j.jep.2018.09.004
• Bonnet, (2017), Substance Abuse and Rehabilitation, pp. 9, 10.2147/SAR.S109576
• Bonn-Miller, (2021), PLoS One, 16, 10.1371/journal.pone.0246990
• Brady, (2004), Multiple Sclerosis Journal, 10, pp. 425, 10.1191/1352458504ms1063oa
• Brand, (2017), Frontiers in Pharmacology, pp. 8
• Brenneisen, R. (2007). Chemistry and analysis of phytocannabinoids and other cannabis constituents. In: Marijuana and the cannabinoids. Marijuana and the Cannabinoids, pp. 17–49.
• Brisbois, (2011), Annals of Oncology, 22, pp. 2086, 10.1093/annonc/mdq727
• Britch, (2021), Psychopharmacology, 238, pp. 9, 10.1007/s00213-020-05712-8
• Bryan, (2021), Journal of Substance Abuse Treatment, 122, 10.1016/j.jsat.2020.108254
• Calignano, (1998), Nature, 394, pp. 277, 10.1038/28393
• Callaway, (2005), Journal of Dermatological Treatment, 16, pp. 87, 10.1080/09546630510035832
• Carod-Artal, (2013), Neurosciences and History, 1, pp. 28
• Carroll, (2004), Neurology, 63, pp. 1245, 10.1212/01.WNL.0000140288.48796.8E
• Centonze, (2007), Brain, 130, pp. 2543, 10.1093/brain/awm160
• Chagas, (2014), Journal of Psychopharmacology, 28, pp. 1088, 10.1177/0269881114550355
• Chagas, (2014), Journal of Clinical Pharmacy and Therapeutics, 39, pp. 564, 10.1111/jcpt.12179
• Chayasirisobhon, (2019), Acta Neurologica Taiwanica, 28, pp. 27
• Cheng, (2014), Journal of Alzheimer’s Disease, 42, pp. 1383, 10.3233/JAD-140921
• Cohen, (2019), Clinical Pharmacology and Therapeutics, 105, pp. 1139, 10.1002/cpt.1381
• Cohen, (2021), Skinmed, 19, pp. 45
• Collin, (2007), European Journal of Neurology, 14, pp. 290, 10.1111/j.1468-1331.2006.01639.x
• Collin, (2010), Neurological Research, 32, pp. 451, 10.1179/016164109X12590518685660
• Consroe, (1991), Pharmacology, Biochemistry, and Behavior, 40, pp. 701, 10.1016/0091-3057(91)90386-G
• Crippa, (2011), Journal of Psychopharmacology, 25, pp. 121, 10.1177/0269881110379283
• Cristino, (2020), Nature Reviews Neurology, 16, pp. 9, 10.1038/s41582-019-0284-z
• Crowley, (2018), Frontiers in Neuroscience, pp. 12
• Curtis, (2009), Movement Disorders, 24, pp. 2254, 10.1002/mds.22809
• Darmani, (2001), Pharmacology, Biochemistry, and Behavior, 69, pp. 239, 10.1016/S0091-3057(01)00531-7
• Darmani, (2001), Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 24, pp. 198, 10.1016/S0893-133X(00)00197-4
• Darmani, (2003), European Journal of Pharmacology, 459, pp. 83, 10.1016/S0014-2999(02)02815-7
• de Carvalho Reis, (2020), Epilepsy & Behavior, 102, 10.1016/j.yebeh.2019.106635
• de Faria, (2020), Journal of Psychopharmacology (Oxford, England), 34, pp. 189, 10.1177/0269881119895536
• Devinsky, (2017), The New England Journal of Medicine, 376, pp. 2011, 10.1056/NEJMoa1611618
• Devinsky, (2016), The Lancet Neurology, 15, pp. 270, 10.1016/S1474-4422(15)00379-8
• Devinsky, (2019), Epilepsia, 60, pp. 294, 10.1111/epi.14628
• Eberlein, (2008), Journal of the European Academy of Dermatology and Venereology, 22, pp. 73
• El Banoua, (2004), Neurobiology of Disease, 16, pp. 377, 10.1016/j.nbd.2004.03.002
• Elder, (2015), Journal of Pediatric Pharmacology and Therapeutics, 20, pp. 462, 10.5863/1551-6776-20.6.462
• Ellert-Miklaszewska, (2007), Brain Research, 1137, pp. 161, 10.1016/j.brainres.2006.12.060
• Ellis, (2009), Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 34, pp. 672, 10.1038/npp.2008.120
• Ellison, (1990), Journal of Clinical Psychiatry, 51, pp. 439
• Epstein, (2010), Skinmed, 8, pp. 95
• Esposito, (2007), British Journal of Pharmacology, 151, pp. 1272, 10.1038/sj.bjp.0707337
• Fakhfouri, (2012), Neuropharmacology, 63, pp. 653, 10.1016/j.neuropharm.2012.05.013
• Femenía, (2010), Alcoholism, Clinical and Experimental Research, 34, pp. 131, 10.1111/j.1530-0277.2009.01074.x
• Fragoso, (2020), Expert Review of Neurotherapeutics, 20, pp. 849, 10.1080/14737175.2020.1776610
• Fraguas-Sánchez, (2018), Drugs, 78, pp. 1665, 10.1007/s40265-018-0996-1
• Fraguas-Sánchez, (2016), Expert Opinion on Investigational Drugs, 25, pp. 1311, 10.1080/13543784.2016.1236913
• Fraguas-Sánchez, (2018), British Journal of Pharmacology, 175, pp. 2566, 10.1111/bph.14331
• Fraser, (2009), CNS Neuroscience and Therapeutics, 15, pp. 84, 10.1111/j.1755-5949.2008.00071.x
• Furgiuele, (2021), Journal of Neuroimmune Pharmacology, 16, pp. 251, 10.1007/s11481-021-09982-7
• Fusar-Poli, (2009), Archives of General Psychiatry, 66, pp. 95, 10.1001/archgenpsychiatry.2008.519
• Gaffal, (2013), Allergy, 68, pp. 994, 10.1111/all.12183
• Gallate, (2004), Psychopharmacology, 173, pp. 210, 10.1007/s00213-003-1694-5
• George, (2010), Psychopharmacology, pp. 37, 10.1007/s00213-009-1704-3
• Giacoppo, (2017), Multiple Sclerosis and Related Disorders, 17, pp. 22, 10.1016/j.msard.2017.06.015
• Glass, (1993), Neuroscience, 56, pp. 523, 10.1016/0306-4522(93)90352-G
• Grimison, (2020), Annals of Oncology, 31, pp. 1553, 10.1016/j.annonc.2020.07.020
• Gross, (2004), Neurology, 62, pp. 2095, 10.1212/01.WNL.0000127623.03766.75
• Gubellini, (2002), Journal of Neuroscience, 22, pp. 6900, 10.1523/JNEUROSCI.22-16-06900.2002
• Guindon, (2007), British Journal of Pharmacology, 150, pp. 693, 10.1038/sj.bjp.0706990
• Gustavsen, (2021), Multiple Sclerosis and Related Disorders, 48
• Hamerle, (2014), European Journal of Neurology, 21, pp. 167, 10.1111/ene.12081
• Haney, (2007), Journal of Acquired Immune Deficiency Syndromes, 45, pp. 545, 10.1097/QAI.0b013e31811ed205
• Haney, (2005), Psychopharmacology, 181, pp. 170, 10.1007/s00213-005-2242-2
• Hanuš, (2016), Natural Product Reports, 33, pp. 1357, 10.1039/C6NP00074F
• Hasan, (2010), Journal of Clinical Psychopharmacology, 30, pp. 190, 10.1097/JCP.0b013e3181d236ec
• Hemming, (1993), Journal of Psychopharmacology, 7, pp. 389, 10.1177/026988119300700411
• Henstridge, (2012), Pharmacology, 89, pp. 179, 10.1159/000336872
• Hill, (2018), Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 43, pp. 80, 10.1038/npp.2017.162
• Hughes, (2019), Neurochemical Research, 44, pp. 703, 10.1007/s11064-018-2513-z
• Hurley, (2003), Journal of Neural Transmission, 110, pp. 1279, 10.1007/s00702-003-0033-7
• Hussain, (2015), Epilepsy & Behavior, 47, pp. 138, 10.1016/j.yebeh.2015.04.009
• Jatoi, (2002), Journal of Clinical Oncology, 20, pp. 567, 10.1200/JCO.2002.20.2.567
• Jean-Gilles, (2009), Journal of the Neurological Sciences, 287, pp. 212, 10.1016/j.jns.2009.07.021
• Jetly, (2015), Psychoneuroendocrinology, 51, pp. 585, 10.1016/j.psyneuen.2014.11.002
• Jiang, (2006), Journal of Ethnopharmacology, 108, pp. 414, 10.1016/j.jep.2006.05.034
• Jin, (2018), PLoS One, 13, 10.1371/journal.pone.0202933
• Joshi, (2019), 1162, pp. 1
• Kaur, (2016), Current Clinical Pharmacology, 11, pp. 110, 10.2174/1574884711666160418105339
• Kavia, (2010), Multiple Sclerosis, 16, pp. 1349, 10.1177/1352458510378020
• Kelly, B. F., & Nappe, T. M. (2021). Cannabinoid Toxicity. StatPearls. Treasure Island.
• Kelsey, (2009), Behavioural Brain Research, 203, pp. 304, 10.1016/j.bbr.2009.04.035
• Kilaru, (2020), Essays in Biochemistry, 64, pp. 485, 10.1042/EBC20190086
• Killestein, (2002), Neurology, 58, pp. 1404, 10.1212/WNL.58.9.1404
• Kleckner, (2019), Therapeutic Advances in Medical Oncology, pp. 11
• Kleine-Brueggeney, (2015), 121, pp. 1157
• Klumpers, (2019), Journal of AOAC International, 102, pp. 412, 10.5740/jaoacint.18-0208
• Koch, (2015), Nature, 519, pp. 45, 10.1038/nature14260
• Kwiatkowska, (2004), Psychopharmacology, 174, pp. 254, 10.1007/s00213-003-1739-9
• LaFrance, (2020), Journal of Affective Disorders, 274, pp. 298, 10.1016/j.jad.2020.05.132
• Lahat, (2012), Digestion, 85, pp. 1, 10.1159/000332079
• Lane, (1991), Journal of Pain and Symptom Management, 6, pp. 352, 10.1016/0885-3924(91)90026-Z
• Laprairie, (2017), Current Opinion in Pharmacology, 32, pp. 32, 10.1016/j.coph.2016.10.005
• Leal-Galicia, (2018), Revista de Neurologia, 67, pp. 133, 10.33588/rn.6704.2017522
• Li, (1973), Economic Botany, 28, pp. 437, 10.1007/BF02862859
• Li, (2020), Trends in Pharmacological Sciences, 41, pp. 665, 10.1016/j.tips.2020.06.010
• Lim, (2019), Journal of Cutaneous Medicine and Surgery, 23, pp. 178, 10.1177/1203475418808761
• López-Sendón Moreno, (2016), Journal of Neurology, 263, pp. 1390, 10.1007/s00415-016-8145-9
• López-Valero, (2018), Biochemical Pharmacology, 157, pp. 275, 10.1016/j.bcp.2018.08.023
• Lynch, (2014), Journal of Pain and Symptom Management, 47, pp. 166, 10.1016/j.jpainsymman.2013.02.018
• Maa, (2014), Epilepsia, 55, pp. 783, 10.1111/epi.12610
• Marcu, (2010), Molecular Cancer Therapeutics, 9, pp. 180, 10.1158/1535-7163.MCT-09-0407
• Marks, (2018), Skin Therapy Letter, 23, pp. 1
• Maurer, (1990), European Archives of Psychiatry and Clinical Neuroscience, 240, pp. 1, 10.1007/BF02190083
• McCoy, (2018), Annals of Clinical and Translational Neurology, 5, pp. 1077, 10.1002/acn3.621
• Mechoulam, (1965), Journal of the American Chemical Society, 87, pp. 3273, 10.1021/ja01092a065
• Meiri, (2007), Current Medical Research and Opinion, 23, pp. 533, 10.1185/030079907X167525
• Metrik, (2011), Drug and Alcohol Dependence, 119, pp. 194, 10.1016/j.drugalcdep.2011.06.004
• Mitrirattanakul, (2007), Alcoholism: Clinical and Experimental Research, 31, pp. 855, 10.1111/j.1530-0277.2007.00366.x
• Mizrachi Zer-Aviv, (2016), Behavioural Pharmacology, 27, 10.1097/FBP.0000000000000253
• Mortati, (2007), Reviews in Neurological Diseases, 4, pp. 103
• Mortimer, (2019), Future Oncology, 15, pp. 1035, 10.2217/fon-2018-0530
• Müller-Vahl, (2002), Pharmacopsychiatry, 35, pp. 57, 10.1055/s-2002-25028
• Narang, (2008), Journal of Pain, 9, pp. 254, 10.1016/j.jpain.2007.10.018
• Notcutt, (2012), Multiple Sclerosis Journal, 18, pp. 219, 10.1177/1352458511419700
• Nurmikko, (2007), Pain, 133, pp. 210, 10.1016/j.pain.2007.08.028
• O’Connell, (2017), Epilepsy & Behavior, 70, pp. 341, 10.1016/j.yebeh.2016.11.012
• Oláh, (2014), Journal of Clinical Investigation, 124, pp. 3713, 10.1172/JCI64628
• Onaivi, (2006), 1074, pp. 514
• Orsolini, (2019), Medicina, 55, pp. 525, 10.3390/medicina55090525
• Parker, (2004), Psychopharmacology, 171, pp. 156, 10.1007/s00213-003-1571-2
• Patel, J. & Marwaha, R. (2021). Cannabis use disorder. Treasure Island:StatPearls.
• Patricio, (2020), Frontiers in Pharmacology, 11, 10.3389/fphar.2020.595635
• Pertwee, (2006), British Journal of Pharmacology, 147, pp. S163, 10.1038/sj.bjp.0706406
• Pisani, (2005), Annals of Neurology, 57, pp. 777, 10.1002/ana.20462
• Pisanti, (2017), Trends in Pharmacological Sciences, 38, pp. 195, 10.1016/j.tips.2016.12.002
• Pisanti, (2019), Journal of Cellular Physiology, 234, pp. 8342, 10.1002/jcp.27725
• Polito, (2018), Pediatric Blood & Cancer, 65, 10.1002/pbc.27374
• Pomeroy, (1986), Cancer Chemotherapy and Pharmacology, 17, pp. 285, 10.1007/BF00256701
• Porter, (2013), Epilepsy & Behavior, 29, pp. 574, 10.1016/j.yebeh.2013.08.037
• Press, (2015), Epilepsy and Behavior, 45, pp. 49, 10.1016/j.yebeh.2015.02.043
• Rakotoarivelo, (2021), Cells, 10, 10.3390/cells10061279
• Ramírez, (2005), Journal of Neuroscience, 25, pp. 1904, 10.1523/JNEUROSCI.4540-04.2005
• Reddy, (2016), Journal of Pharmacology and Experimental Therapeutics, 357, pp. 45, 10.1124/jpet.115.230151
• Richfield, (1994), Annals of Neurology, 36, pp. 577, 10.1002/ana.410360406
• Riggs, (2012), Brain Research, 1431, pp. 46, 10.1016/j.brainres.2011.11.001
• Rock, (2016), European Journal of Pharmacology, 786, pp. 94, 10.1016/j.ejphar.2016.06.001
• Rog, (2007), Clinical Therapeutics, 29, pp. 2068, 10.1016/j.clinthera.2007.09.013
• Rog, (2005), Neurology, 65, pp. 812, 10.1212/01.wnl.0000176753.45410.8b
• Russo, (2011), British Journal of Pharmacology, 163, pp. 1344, 10.1111/j.1476-5381.2011.01238.x
• Salazar, (2009), Journal of Clinical Investigation, 119, pp. 1359, 10.1172/JCI37948
• Sallan, (1975), New England Journal of Medicine, 293, pp. 795, 10.1056/NEJM197510162931603
• Sánchez, (2001), Cancer Research, 61, pp. ), 5784
• Sands, (2019), CNS Drugs, 33, pp. 47, 10.1007/s40263-018-0589-2
• Sandyk, (1988), Journal of Clinical Psychopharmacology, 8, pp. 444, 10.1097/00004714-198812000-00021
• Schley, (2009), Brain Research Bulletin, 79, pp. 333, 10.1016/j.brainresbull.2009.01.011
• Seltzer, (2020), Cancers, 12, pp. 1, 10.3390/cancers12113203
• Serpell, (2013), Journal of Neurology, 260, pp. 285, 10.1007/s00415-012-6634-z
• Serrano, (2012), Alcoholism: Clinical and Experimental Research, 36, pp. 984, 10.1111/j.1530-0277.2011.01686.x
• Shahbazi, (2020), iScience, 23, 10.1016/j.isci.2020.101301
• Sharkey, (2007), European Journal of Neuroscience, 25, pp. 2773, 10.1111/j.1460-9568.2007.05521.x
• Sharon, (2019), Current Opinion in Anaesthesiology, 32, pp. 623, 10.1097/ACO.0000000000000775
• Soelberg Sorensen, (2017), Acta Neurologica Scandinavica, 136, pp. 168, 10.1111/ane.12712
• Solas, (2013), Neurobiology of Aging, 34, pp. 805, 10.1016/j.neurobiolaging.2012.06.005
• Soyka, (2008), Journal of Clinical Psychopharmacology, 28, pp. 317, 10.1097/JCP.0b013e318172b8bc
• Stampanoni Bassi, (2017), Cannabis and Cannabinoid Research, 2, pp. 21, 10.1089/can.2017.0002
• Starowicz, (2012), Neuropharmacology, 62, pp. 1746, 10.1016/j.neuropharm.2011.11.021
• Sticht, (2013), Physiology & Behavior, 120, pp. 228, 10.1016/j.physbeh.2013.08.015
• Strasser, (2006), Journal of Clinical Oncology, 24, pp. 3394, 10.1200/JCO.2005.05.1847
• Suhre, (2020), BMC Anesthesiology, 20, 10.1186/s12871-020-01036-4
• Svendsen, (2004), BMJ (Clinical Research ed.), 329, pp. 253, 10.1136/bmj.38149.566979.AE
• Thanos, (2005), Behavioural Brain Research, 164, pp. 206, 10.1016/j.bbr.2005.06.021
• Thiele, (2018), The Lancet, 391, pp. 1085, 10.1016/S0140-6736(18)30136-3
• Thiele, (2019), Epilepsia, 60, pp. 419, 10.1111/epi.14670
• Toth, (2012), Pain, 153, pp. 2073, 10.1016/j.pain.2012.06.024
• Trainor, (2016), Australasian Psychiatry, 24, pp. 541, 10.1177/1039856216663737
• Treat, (2017), Epilepsia, 58, pp. 123, 10.1111/epi.13617
• Turcotte, (2015), Pain Medicine, 16, pp. 149, 10.1111/pme.12569
• Twelves, (2021), British Journal of Cancer, 124, pp. 1379, 10.1038/s41416-021-01259-3
• Tzadok, (2016), Seizure: The Journal of the British Epilepsy Association, 35, pp. 41, 10.1016/j.seizure.2016.01.004
• Uliel-Sibony, (2021), Brain and Development, 43, pp. 89, 10.1016/j.braindev.2020.06.018
• Ungerleider, (1988), Advances in Alcohol and Substance Abuse, 7, pp. 39, 10.1300/J251v07n01_04
• Van De Donk, (2019), Pain, 160, pp. 860, 10.1097/j.pain.0000000000001464
• Van Sickle, (2005), Science (New York, N.Y.), pp. 329, 10.1126/science.1115740
• Volicer, (1997), International Journal of Geriatric Psychiatry, 12, pp. 913, 10.1002/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D
• Wade, (2004), Multiple Sclerosis, 10, pp. 434, 10.1191/1352458504ms1082oa
• Wade, (2003), Clinical Rehabilitation, 17, pp. 21, 10.1191/0269215503cr581oa
• Walsh, (2020), Addictive Behaviors, 100, 10.1016/j.addbeh.2019.106121
• Ware, (2010), CMAJ: Canadian Medical Association Journal=Journal de l’Association Medicale Canadienne, 182, pp. E694, 10.1503/cmaj.091414
• Weerts, (2008), Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 33, pp. 653, 10.1038/sj.npp.1301440
• Wilsey, (2013), Journal of Pain, 14, pp. 136, 10.1016/j.jpain.2012.10.009
• Wilsey, (2008), Journal of Pain, 9, pp. 506, 10.1016/j.jpain.2007.12.010
• Wissel, (2006), Journal of Neurology, 253, pp. 1337, 10.1007/s00415-006-0218-8
• Zajicek, (2012), Journal of Neurology, Neurosurgery, and Psychiatry, 83, pp. 1125, 10.1136/jnnp-2012-302468
• Zuardi, (2006), Revista Brasileira de Psiquiatria, 28, pp. 153, 10.1590/S1516-44462006000200015
• Zuardi, (1993), Journal of Psychopharmacology, 7, pp. 82, 10.1177/026988119300700112